Regulation of HLA class II expression and its role in autoimmune disease. by Feldmann, M

Immunotherapy - Editorial overview by Feldmann, M

Cellular components of the immune system and their cooperation (T and B cells). by Feldmann, M

T cell suppression in vitro. II. Nature of specific suppressive factor. by Feldmann, M

Cytokine networks: do we understand them well enough to facilitate clinical benefits? by Feldmann, M

Are the Ir genes expressed by macrophages? by Feldmann, M

Cell to cell interactions in the immune response. by Feldmann, M

Pathogenesis of arthritis: recent research progress. by Feldmann, M

T cell suppression in vitro. I. Role in regulation of antibody responses. by Feldmann, M

Development of anti-TNF therapy for rheumatoid arthritis. by Feldmann, M

Cell interactions in the immune response in vitro. V. Specific collaboration via complexes of antigen and thymus-derived cell immunoglobulin. by Feldmann, M

A view from a European medical academic who spends time in the US. by Feldmann, M

Induction of immunity and tolerance in vitro by hapten protein conjugates. II. Carrier independence of the response to dinitrophenylated polymerized flagellin. by Feldmann, M

The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target. by Feldmann, M

T-cell activation in health and disease. by Feldmann, M

Role of T-cell antigen-specific factor in T-B cooperation. by Feldmann, M

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis? by Feldmann, M

Mechanism of action of immune response genes by Feldmann, M

The TNF/TNF-R family: A gold mine for clinical therapeutic targets? by Feldmann, M

Translating molecular insights in autoimmunity into effective therapy. by Feldmann, M